Friday, June 19, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 906 of 1,261
  1. US 8268999

    Tri-cyclic pyrazolopyridine kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Sep 18, 2012 · Expires Sep 13, 2032

    granted
  2. US 8268894

    Compositions and methods for the treatment of infectious diseases

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 18, 2012 · Expires Sep 13, 2032

    granted
  3. US 8268890

    Method of treating ischemia/reperfusion injury with nitroxyl donors

    The United States of America, as represented by the Secretary, Health and Human Services · Granted Sep 18, 2012 · Expires Sep 13, 2032

    granted
  4. US 8269013

    Substituted pyrazole inhibitors of c-Met protein kinase

    Vertex Pharmaceuticals Incorporated · Granted Sep 18, 2012 · Expires Sep 13, 2032

    granted
  5. US 8268863

    Disubstituted alkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

    Theravance, Inc. · Granted Sep 18, 2012 · Expires Sep 13, 2032

    granted
  6. US 8269026

    Lupane derivatives useful for treating HIV

    Vertex Pharmaceuticals Incorporated · Granted Sep 18, 2012 · Expires Sep 13, 2032

    granted
  7. US 8268873

    Inhibitors of IMPDH enzyme

    Vertex Pharmaceuticals Incorporated · Granted Sep 18, 2012 · Expires Sep 13, 2032

    granted
  8. US 8268336

    Compositions containing aromatic aldehydes and their use in treatments

    SkinMedica, Inc. · Granted Sep 18, 2012 · Expires Sep 13, 2032

    granted
  9. US 8268776

    Macrocylic oximyl hepatitis C protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Sep 18, 2012 · Expires Sep 13, 2032

    granted
  10. US 8263661

    Development of new selective estrogen receptor modulators

    The Regents of the University of California · Granted Sep 11, 2012 · Expires Sep 6, 2032

    granted
  11. US 8263776

    Inhibitors of c-Met protein kinase

    Vertex Pharmaceuticals Incorporated · Granted Sep 11, 2012 · Expires Sep 6, 2032

    granted
  12. US 8263606

    Spiro-oxindole compounds and their use as therapeutic agents

    Xenon Pharmaceuticals Inc. · Granted Sep 11, 2012 · Expires Sep 6, 2032

    granted
  13. US 8263588

    Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

    Neurocrine Biosciences, Inc. · Granted Sep 11, 2012 · Expires Sep 6, 2032

    granted
  14. US 8263605

    Modulators of muscarinic receptors

    Vertex Pharmaceuticals Incorporated · Granted Sep 11, 2012 · Expires Sep 6, 2032

    granted
  15. US 8263618

    8-azabicyclo[3.2.1]octane compounds as MU opioid receptor antagonists

    Theravance, Inc. · Granted Sep 11, 2012 · Expires Sep 6, 2032

    granted
  16. US 8263650

    Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy

    Jazz Pharmaceuticals, Inc. · Granted Sep 11, 2012 · Expires Sep 6, 2032

    granted
  17. US 8263677

    Removable color gel basecoat for artificial nail coatings and methods therefore

    Creative Nail Design Inc. · Granted Sep 11, 2012 · Expires Sep 6, 2032

    granted
  18. US 8263762

    Alkoxy-carbonyl-amino-alkynyl-adenosine compounds and derivatives thereof as A2AR agonists

    Dogwood Pharmaceuticals, Inc. · Granted Sep 11, 2012 · Expires Sep 6, 2032

    granted
  19. US 8263747

    Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins

    The Regents of the University of California · Granted Sep 11, 2012 · Expires Sep 6, 2032

    granted
  20. US 8263759

    Sets of probes and primers for the diagnosis of select cancers

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 11, 2012 · Expires Sep 6, 2032

    granted
  21. US 8263662

    Methods of treating non-alcoholic steatohepatitis (NASH) using cysteamine products

    The Regents of the University of California · Granted Sep 11, 2012 · Expires Sep 6, 2032

    granted
  22. US 8263651

    Use of cis-epoxyeicosatrienoic acids and inhibitors of soluble epoxide hydrolase to treat conditions mediated by PBR, CB2, and NK2 receptors

    The Regents of the University of California · Granted Sep 11, 2012 · Expires Sep 6, 2032

    granted
  23. US 8263777

    Aminopyrazole triazolothiadiazole inhibitor of c-Met protein kinase

    Vertex Pharmaceuticals Incorporated · Granted Sep 11, 2012 · Expires Sep 6, 2032

    granted
  24. US 8263091

    Method of treating and preventing infections in immunocompromised subjects with immunostimulatory CpG oligonucleotides

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Sep 11, 2012 · Expires Sep 6, 2032

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.